1. Home
  2. LXRX vs BBBY Comparison

LXRX vs BBBY Comparison

Compare LXRX & BBBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • BBBY
  • Stock Information
  • Founded
  • LXRX 1995
  • BBBY 1971
  • Country
  • LXRX United States
  • BBBY United States
  • Employees
  • LXRX N/A
  • BBBY N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • BBBY
  • Sector
  • LXRX Health Care
  • BBBY
  • Exchange
  • LXRX Nasdaq
  • BBBY Nasdaq
  • Market Cap
  • LXRX 541.5M
  • BBBY 573.5M
  • IPO Year
  • LXRX 2000
  • BBBY N/A
  • Fundamental
  • Price
  • LXRX $1.34
  • BBBY $5.60
  • Analyst Decision
  • LXRX Buy
  • BBBY Hold
  • Analyst Count
  • LXRX 5
  • BBBY 1
  • Target Price
  • LXRX $3.23
  • BBBY $8.00
  • AVG Volume (30 Days)
  • LXRX 2.3M
  • BBBY 2.0M
  • Earning Date
  • LXRX 11-06-2025
  • BBBY 10-27-2025
  • Dividend Yield
  • LXRX N/A
  • BBBY N/A
  • EPS Growth
  • LXRX N/A
  • BBBY N/A
  • EPS
  • LXRX N/A
  • BBBY N/A
  • Revenue
  • LXRX $70,864,000.00
  • BBBY $1,074,337,000.00
  • Revenue This Year
  • LXRX $66.55
  • BBBY N/A
  • Revenue Next Year
  • LXRX N/A
  • BBBY $5.03
  • P/E Ratio
  • LXRX N/A
  • BBBY N/A
  • Revenue Growth
  • LXRX 1255.21
  • BBBY N/A
  • 52 Week Low
  • LXRX $0.28
  • BBBY $3.54
  • 52 Week High
  • LXRX $1.66
  • BBBY $12.65
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 44.82
  • BBBY 25.78
  • Support Level
  • LXRX $1.36
  • BBBY $5.58
  • Resistance Level
  • LXRX $1.52
  • BBBY $6.15
  • Average True Range (ATR)
  • LXRX 0.13
  • BBBY 0.41
  • MACD
  • LXRX -0.01
  • BBBY -0.09
  • Stochastic Oscillator
  • LXRX 32.61
  • BBBY 3.20

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About BBBY Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc is an ecommerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering a comprehensive array of products and services that enable its customers to enhance everyday life through quality, style, and value. The Company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites as well as a blockchain asset portfolio.

Share on Social Networks: